---
figid: PMC8187902__fonc-11-651541-g003
figtitle: 'Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy
  of the Molecular Mechanisms'
organisms:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- mixed culture
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC8187902
filename: fonc-11-651541-g003.jpg
figlink: /pmc/articles/PMC8187902/figure/f3/
number: F3
caption: 'Resistance to CDK4/6 inhibitors: Indirect Cell Cycle Mechanism Bypass pathways
  of the cell cycle: mTOR activation is via phosphoinositide PI3K/AKT signaling. The
  PI3K/AKT/mTOR pathway regulate cell signal transduction, have extensive links with
  other bypasses, for example EMT and TGF-β pathway (, , –). High expression of AP-1
  (–), FGFR amplification (–), loss of ER or PR (, , , ) expression drives cells to
  escape CDK4/6 inhibition and act as bypass pathways for the progression of the cell.
  Other mechanisms include EMT (, –), immune mechanisms (–) and autophagy directly
  or indirectly influence drug resistance shown in the figure (, –).'
papertitle: 'Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors:
  Intricacy of the Molecular Mechanisms.'
reftext: Bin Wang, et al. Front Oncol. 2021;11:651541.
year: '2021'
doi: 10.3389/fonc.2021.651541
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: breast cancer | CDK4/6 inhibitors | drug resistance | molecular mechanisms
  | combination administration
automl_pathway: 0.9177602
figid_alias: PMC8187902__F3
figtype: Figure
redirect_from: /figures/PMC8187902__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8187902__fonc-11-651541-g003.html
  '@type': Dataset
  description: 'Resistance to CDK4/6 inhibitors: Indirect Cell Cycle Mechanism Bypass
    pathways of the cell cycle: mTOR activation is via phosphoinositide PI3K/AKT signaling.
    The PI3K/AKT/mTOR pathway regulate cell signal transduction, have extensive links
    with other bypasses, for example EMT and TGF-β pathway (, , –). High expression
    of AP-1 (–), FGFR amplification (–), loss of ER or PR (, , , ) expression drives
    cells to escape CDK4/6 inhibition and act as bypass pathways for the progression
    of the cell. Other mechanisms include EMT (, –), immune mechanisms (–) and autophagy
    directly or indirectly influence drug resistance shown in the figure (, –).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CDK6
  - CDK4
  - ITK
  - SLC22A3
  - TGFB1
  - TGFB2
  - TGFB3
  - IL2
  - EGFR
  - ERBB2
  - JUN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FOS
  - FOSB
  - JUNB
  - JUND
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - GDNF
  - PLAU
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - MTOR
  - ESR1
  - CDK2
  - PRB1
  - RBL1
  - SP1
  - PSG1
  - DAND5
  - FOXA1
  - TFF1
  - FABP4
  - GTF3A
  - TFAP2A
  - Pdcd1
  - Cdk6
  - Cdk4
  - Itk
  - Slc22a3
  - Tgfb1
  - Ltbp1
  - Il2
  - Egfr
  - Erbb2
  - Jun
  - Pik3r1
  - Akt1
  - Fos
  - Gdnf
  - Maf
  - pr
  - Mtor
  - Esr1
  - Cdk2
  - Rbl1
  - Prb1a
  - Sp1
  - Foxa1
  - Tff1
  - Fabp4
  - Tfap2a
  - cdk6
  - cdk4
  - egfra
  - erbb2
  - jun
  - fosab
  - mafa
  - mafb
  - mtor
  - esr1
  - akap12b
  - cdk2
  - prb1
  - sp1
  - foxa1
  - tfap2a
---
